01 SODIUM NITROPRUSSIDE (3)
01 EXELA PHARMA (3)
01 SOLUTION;INTRAVENOUS (3)
01 10MG/50ML (0.2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
02 20MG/100ML (0.2MG/ML) (1)
03 50MG/100ML (0.5MG/ML) (1)
01 USA (3)
19
Exela Pharma Sciences, LLC., based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is SODIUM NITROPRUSSIDE, with a corresponding application number 209387 and regulatory information .
proudly manufactured in the
approval since 2017-03-08
Exela Pharma Sciences, LLC.'s NIPRIDE RTU IN SODIUM CHLORIDE 0.9% SOLUTION;INTRAVENOUS, medication with 50MG/100ML (0.5MG/ML) of SODIUM NITROPRUSSIDE.
18
Exela Pharma Sciences, LLC., based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is SODIUM NITROPRUSSIDE, with a corresponding application number 209387 and regulatory information .
proudly manufactured in the
approval since 2017-12-07
Exela Pharma Sciences, LLC.'s NIPRIDE RTU IN SODIUM CHLORIDE 0.9% SOLUTION;INTRAVENOUS, medication with 10MG/50ML (0.2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of SODIUM NITROPRUSSIDE.
17
Exela Pharma Sciences, LLC., based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is SODIUM NITROPRUSSIDE, with a corresponding application number 209387 and regulatory information .
proudly manufactured in the
approval since 2018-07-13
Exela Pharma Sciences, LLC.'s NIPRIDE RTU IN SODIUM CHLORIDE 0.9% SOLUTION;INTRAVENOUS, medication with 20MG/100ML (0.2MG/ML) of SODIUM NITROPRUSSIDE.